Carnosine supplementation improves cognitive outcomes in younger participants of the NEAT trial.
Ontology highlight
ABSTRACT: Some prior studies suggested that supplementation with carnosine or β-alanine can improve cognitive abilities and neurodegenerative disorders in certain elderly or at-risk populations. However, the efficacy of carnosine in improving cognitive performance in a healthy, adult population has not been assessed. We examined this as a post-hoc secondary outcome in the placebo-controlled, randomized Nucleophilic Defense Against PM Toxicity (NEAT) clinical trial (NCT03314987). Participants in this trial were instructed to take either cornstarch (placebo) or carnosine capsules (2g daily) for up to 12wk. Cognitive ability was assessed using the Cognition test battery, which consists of ten individual tests known to engage specific brain systems and covering a range of cognitive domains. Speed, accur
SUBMITTER: O'Toole TE
PROVIDER: S-EPMC12014415 | biostudies-literature | 2025 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA